Participated · Series A · Jun 2023

Luminoah is developing a reinvented tube-feeding device that is more portable, discreet and easy to use than traditional IV-pole‑mounted infusion pumps. Founder Neal Piper was motivated to start the company after his toddler required prolonged tube feeding during cancer treatment. The company says it has substantially reduced hardware size and is designing a modern UI/UX to allow users to go about their day unencumbered. The design is not final and Luminoah is not yet publishing images of the device. As a connected device, it will collect feeding metrics that medical providers can review similar to hospital systems. Luminoah plans to make the device reimbursable by insurance and will use funding to advance development, reach prototype stage, prepare for commercialization, and grow the team.

Participated · Series A · May 2020

Embody develops collagen-based bio-fabrication techniques and products for the sports medicine market, including solutions for rotator cuff repair, foot & ankle, and knee ligament procedures. The company offers a platform of products such as the recently launched Tapestry RC System for rotator cuff repair. Embody is preparing a commercial launch of its ActivBraid™ high-strength collagen-based suture technology in 2023. Leadership is headed by CEO Jeff Conroy. Financially, the company has received more than $23M in DARPA and DoD funding to date and recently completed a $10.4M Series C. Embody intends to use the new funds to expand operations and conduct post-market clinical studies of the Tapestry RC System. Embody is advancing a regenerative platform for repair of tendon and ligament injuries using novel collagen-based bio-fabrication techniques. Its lead product is Tapestry®, a next-generation soft-tissue repair technology targeted at the sports medicine market. The company is developing biomaterials for orthopedic applications including Achilles, rotator cuff and knee ligament repair, including ACL. Led by co-founder and CEO Jeff Conroy, Embody plans to expand its team and commercially launch Tapestry in the second half of 2020. Founded in 2014 and based in Norfolk, Va., the company had previously received $20 million in DARPA and DOD funding. It closed a $9.3m Series A in May 2020 to support growth and commercialization efforts. Embody is a regenerative medicine company focused on developing and commercializing implantable medical devices. Its lead product, Tapestry, is a collagen-based microfiber implant designed for Achilles and rotator cuff repairs. Tapestry’s design leverages research showing collagen accelerates recellularization by promoting growth of aligned tissue over surgical repairs. The company says the product targets a combined U.S. market exceeding 750,000 surgical cases annually. Embody is led by CEO Jeff Conroy and is based in Norfolk, Virginia. It intends to use the new funding for pre-launch and pre-commercial activities. Product development has been funded in part by $12.1M in DARPA funding and an R&D contract. Embody develops collagen-based implantable medical devices designed to treat tendon and ligament injuries by promoting faster healing and restoring pre-injury performance. The company focuses on applications for warfighters and sports medicine patients. Led by CEO Jeff Conroy, Embody intends to advance treatment standards for soft tissue injuries. Recently it raised a convertible debt funding round (amount undisclosed) to support these efforts. The company has previously been funded with $12M from DARPA to further development for warfighters and veterans. Embody aims to improve the standard of care for soft tissue injuries through its implantable products.

Participated · Seed · Sep 2019

Fenris builds API-delivered pre-fill data and technology products designed to optimize and enable a friction-free application and quoting experience for insurers and financial services providers. Its suite includes LicenseSnap, which embeds into online forms and starts the process from a photo of a driver’s license to reduce poor data entry and mid-application abandonment. The company maintains a data repository of over 400 million records and has scored millions of applications, and it offers predictive scores for propensity to buy, lifetime value, churn risk, cross-sell potential, and financial responsibility. Over the last 12 months Fenris expanded sales operations and enhanced its data delivery and analytics platform. Fenris says clients see increased conversion rates, a 25% decrease in cost of acquisition from smarter report ordering, and up to an 80% reduction in manual effort. The company plans to use the additional funding to further build out its product suite to meet demand from current and prospective clients. Fenris Digital builds software and analytics solutions enabling applications for financial and insurance products. The company maintains a proprietary, in-house repository of over 300 million entity records and accompanying data elements from qualified and emerging sources. By applying machine learning to its repository and millions of policy-result records across dozens of personal, commercial, and life insurers, Fenris generates predictive algorithms including MatchScore, TriageScore, LeadScreen and PFR (Personal Financial Responsibility). Led by Founder and CEO Jennifer Linton and based in Richmond, Va., the company plans to expand operations and continue product development. It intends to use the funds to hire sales, strategic business development, customer success, engineering, and data analytics talent and to further build out its product suite. The company disclosed a $1.7M seed financing as its current funding event.

Participated · Seed · Mar 2019

Ario Technologies builds an AR SaaS productivity platform used by industrial companies, including Fortune 500 firms, to increase productivity, connect data with equipment, reduce training time and capture workforce knowledge. The platform offers augmented reality software tools aimed at the industrial workforce. The company was founded in 2016 by CEO Joe Weaver and COO Nate Fender and is based in Norfolk, VA. Ario plans to use recent funding to expand its market presence in the United States and internationally and to continue iterating on its product offerings. Its current funding includes a venture capital round and a U.S. Air Force SBIR grant that together provide early-stage capital for growth. No revenue or user metrics were disclosed in the article. Ario Technologies develops Ario, an augmented reality software-as-a-service platform that lets teams create and share real-time spatial information using real-world data. The platform is positioned for industrial enterprise use, with applications in training, reducing manufacturing downtime, improving safety, and providing remote expert assistance. The company intends to use recent funding to expand its industrial enterprise product offering and accelerate its go-to-market strategy. Ario emphasizes real-time spatial collaboration in physical environments rather than purely virtual experiences. The product targets organizations seeking operational efficiencies and remote support capabilities in industrial settings. No operating metrics were disclosed in the article.